Insulinoma
32
4
5
11
Key Insights
Highlights
Success Rate
73% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
12.5%
4 terminated out of 32 trials
73.3%
-13.3% vs benchmark
0%
0 trials in Phase 3/4
55%
6 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 11 completed trials
Clinical Trials (32)
Diagnosing and Treating Low Blood Sugar Levels
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors
Comparison of [68Ga]Ga-HBED-CC-PEG6-Exendin-4 and [68Ga]Ga-HBED-CC-Exendin-4 PET/CT for Insulinoma Localization
Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease
DOTATOC PET/CT for Imaging NET Patients
18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia
Clinical Study of 18F-Exendin-4 in Insulinoma
Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma
Capecitabine, Temozolomide, and Bevacizumab for Metastatic or Unresectable Pancreatic Neuroendocrine Tumors
CGM (Continuous Glucose Monitoring) Use in Diagnosis of Spontaneous and Reactive Hypoglycaemia
A Multi-center Study to Evaluate the Efficacy and Safety of Pancreatic Duct Stents Placement Before the Enucleation of Insulinoma Located in the Head and Neck of the Pancreas Near the Main Pancreatic Duct
The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery
177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs
18F-FDOPA PET in Neuroendocrine Tumours
[68Ga]Ga-HBED-CC-exendin-4 and [68Ga]Ga-NOTA-exendin-4 PET/CT Imaging in the Same Group of Insulinoma Patients
Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors
68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH
Pasireotide in Hyperinsulinemic Hypoglycemia